DK3862015T3 - Peptider til anvendelse ved behandling af inflammatorisk colitis - Google Patents

Peptider til anvendelse ved behandling af inflammatorisk colitis Download PDF

Info

Publication number
DK3862015T3
DK3862015T3 DK19855142.6T DK19855142T DK3862015T3 DK 3862015 T3 DK3862015 T3 DK 3862015T3 DK 19855142 T DK19855142 T DK 19855142T DK 3862015 T3 DK3862015 T3 DK 3862015T3
Authority
DK
Denmark
Prior art keywords
peptides
treatment
inflammatory colitis
colitis
inflammatory
Prior art date
Application number
DK19855142.6T
Other languages
English (en)
Inventor
Yoon Jeong Park
Chong-Pyoung Chung
Jue-Yeon Lee
Original Assignee
Nibec Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nibec Co Ltd filed Critical Nibec Co Ltd
Priority claimed from PCT/KR2019/011037 external-priority patent/WO2020046002A1/ko
Application granted granted Critical
Publication of DK3862015T3 publication Critical patent/DK3862015T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1729—Cationic antimicrobial peptides, e.g. defensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK19855142.6T 2018-08-31 2019-08-29 Peptider til anvendelse ved behandling af inflammatorisk colitis DK3862015T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20180103615 2018-08-31
KR1020190105917A KR102244161B1 (ko) 2018-08-31 2019-08-28 다중의 질환 바이오마커의 기능 및 발현을 억제하는 펩타이드의 신규한 용도
PCT/KR2019/011037 WO2020046002A1 (ko) 2018-08-31 2019-08-29 다중의 질환 바이오마커의 기능 및 발현을 억제하는 펩타이드의 신규한 용도

Publications (1)

Publication Number Publication Date
DK3862015T3 true DK3862015T3 (da) 2024-04-22

Family

ID=69800621

Family Applications (1)

Application Number Title Priority Date Filing Date
DK19855142.6T DK3862015T3 (da) 2018-08-31 2019-08-29 Peptider til anvendelse ved behandling af inflammatorisk colitis

Country Status (5)

Country Link
US (2) US20210340182A1 (da)
EP (2) EP3862015B1 (da)
KR (1) KR102244161B1 (da)
CN (1) CN112912093A (da)
DK (1) DK3862015T3 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115737616A (zh) * 2021-11-29 2023-03-07 南方医科大学南方医院 Lmk-235在医学中的新应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002040512A2 (de) * 2000-11-14 2002-05-23 Ipf Pharmaceuticals Gmbh Humanes beta-defensin-3
KR20110031970A (ko) * 2008-07-18 2011-03-29 노보자임스 아데니움 바이오테크 에이/에스 포유류 베타 방어소를 사용한 류마티스성 관절염의 치료
EP2320930A2 (en) * 2008-07-18 2011-05-18 Novozymes Adenium Biotech A/S Treatment of inflammatory bowel diseases with mammal beta defensins
KR101320472B1 (ko) * 2010-06-16 2013-10-23 주식회사 나이벡 항균 또는 항염증 활성을 가지는 펩타이드 및 이를 유효성분으로 함유하는 약제학적 조성물
JP6219277B2 (ja) * 2011-07-08 2017-10-25 ディフェンシン セラピューティクス アンパルトセルスカブＤｅｆｅｎｓｉｎ Ｔｈｅｒａｐｅｕｔｉｃｓ Ａｐｓ 炎症性腸疾患の経口治療
KR101693533B1 (ko) * 2015-03-26 2017-01-06 서울대학교산학협력단 암줄기세포의 성장억제용 항암기능성 펩타이드 및 그 용도
KR101906557B1 (ko) * 2015-08-06 2018-10-11 서울대학교산학협력단 합성 펩타이드를 이용한 유도만능줄기세포의 제조방법
CN105288590A (zh) * 2015-11-03 2016-02-03 昆明理工大学 一种人防御素蛋白的新用途
KR102465341B1 (ko) * 2016-04-29 2022-11-09 디펜신 테라퓨틱스 에이피에스 간, 담관 및 췌장 장애의 치료
KR101979932B1 (ko) * 2017-08-18 2019-05-21 서울대학교산학협력단 골 흡수 억제용 펩타이드
CA3082288A1 (en) * 2017-11-10 2019-05-16 Defensin Therapeutics Aps Maturation of mucosal defense and gut/lung function in the preterm infant
BR112020010180A2 (pt) * 2017-11-24 2021-01-12 Defensin Therapeutics Aps B-defensina e/ou a-defensina humana para uso na prevenção ou no tratamento de doença do enxerto contra hospedeiro aguda
KR102631543B1 (ko) * 2018-03-14 2024-02-01 서울대학교산학협력단 세포 투과능 및 근육 재생능을 가지는 이중 기능성 펩타이드 및 이의 용도
KR102631542B1 (ko) * 2018-03-14 2024-02-01 서울대학교산학협력단 염증 감소능 및 줄기세포로부터 연골세포로의 분화 촉진능을 가지는 이중 기능성 펩타이드 및 이의 용도
EP3845551A4 (en) * 2018-08-31 2022-06-22 Nibec Co., Ltd. NEW PEPTIDE CAPABLE OF BINDING TO A BIOMARKER OF INFLAMMATORY AND METABOLIC DISEASES AND THE USE OF IT

Also Published As

Publication number Publication date
CN112912093A (zh) 2021-06-04
EP3862015B1 (en) 2024-03-13
EP3862015A4 (en) 2022-07-06
EP4218788A1 (en) 2023-08-02
US20210340182A1 (en) 2021-11-04
KR20200026122A (ko) 2020-03-10
US20240166688A1 (en) 2024-05-23
KR102244161B1 (ko) 2021-04-26
EP3862015A1 (en) 2021-08-11

Similar Documents

Publication Publication Date Title
DK3240554T3 (da) Blautia stercosis og wexlerae til anvendelse til behandling af inflammatoriske og autoimmune sygdomme
DK3185957T3 (da) Patisiran til anvendelse ved behandlingen af transthyretin-medieret amyloidosis
DK3119797T3 (da) Raav-baserede sammensætninger og fremgangsmåder til behandling af amyotrofisk lateralsklerose
DK3197472T3 (da) Rekombinante phe-frie proteiner til anvendelse i behandlingen af phenylketonuri
DK3096798T3 (da) Plasmakallikreinbindende proteiner og anvendelser deraf til behandling af hereditært angioødem
DK3172227T3 (da) Molekyler der selektivt aktiverer regulatoriske t-celler til behandlingen af autoimmune sygdomme
DK3481846T3 (da) 11-substituerede 24-hydroxysteroler til anvendelse til behandling af nmda-relaterede tilstande
DK3668509T3 (da) Fremgangsmåde til behandling af amyotrofisk lateralsklerose med pridopidin
DK3307296T3 (da) Timp2 til anvendelse til behandling af aldringsassocierede tilstande
DK3390390T3 (da) Bipyrazolylderivater egnede til behandling af autoimmunsygdomme
DK3865484T3 (da) Pde9-hæmmer med imidazopyrazinon-rygrad til behandling af perifere sygdomme
DK3331879T3 (da) Benzazolforbindelser og fremgangsmåder til fremstilling og anvendelse af forbindelserne
DK3556383T3 (da) Plasminogen til anvendelse ved behandling af diabetes
DK3391902T3 (da) Plasminogen til anvendelse i behandlingen af diabetisk angiokardiopati
DK3242947T3 (da) Genterapi og elektroporese til behandling af maligniteter
DK3430143T3 (da) Inhibitorer af SRSF1 til behandlingen af neurodegenerative sygdomme
DK3522904T3 (da) Flydende sammensætning til anvendelse i behandlingen af gastroesophageal reflux
DK3570940T3 (da) Pridopidin til anvendelse i behandling af fragilt x-syndrom
DK3149049T3 (da) Il-22 til anvendelse til behandling af stofskiftesygdomme
DK3618845T3 (da) Peptider til behandling af diabetes
DK3551189T3 (da) Alprazolam til anvendelse ved behandling af epilepsi
DK3286317T3 (da) Dynamin 2-inhibitor til behandlingen af duchennes muskeldystrofi
DK3506901T3 (da) Anvendelse af kynurensyre til behandling af muskelatrofi
DK3423060T3 (da) Imatinib til anvendelse til behandling af slagtilfælde
DK3522873T3 (da) Sammensætninger og fremgangsmåder til behandlingen af xerostomi